Streetwise Reports' Article Archives — Current Month (15)

Streetwise Live! Presents White Gold: Reasons to Invest in Leading Explorer, Largest Landholder in Yukon Gold District (12/06/2021)

In a Streetwise Live! Broadcast on Dec. 6, 2021, Stifel analyst Stephen Soock noted why now is a good time to invest in gold and, specifically, in White Gold Corp. Two of the companies' executives, David D'Onofrio, CEO, and Shawn Ryan, co-founder and technical adviser, shared what differentiates this exploration company from others and what it offers investors.

more>

White Gold Gets Infusion of Capital, Knowledge (12/06/2021)

White Gold Corp. will use an investment of CA$9 million through strategic partner and investor Agnico Eagle Mines Ltd. for working capital and general corporate purposes. But the transaction has another benefit: It gives White Gold access to a tremendous level of expertise across all areas of mining.

more>

Medical Device Firm Engages Distributor for Its TransDermal Infusion System (12/06/2021)

Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted.

more>

Phase Two Studies Start For Therapy For Chemo-Treated Breast Cancer Patients (12/06/2021)

New clinical trials for G1 Therapeutics’ Cosela are “central to our investment thesis,” H.C. Wainright & Co. noted in a new research report.

more>

Biopharma Launches Clinical Trial of Primary Asset in Endometrial Cancer (12/06/2021)

"Solid tumors offers a substantial opportunity for Karyopharm Therapeutics' Xpovio (selinexor) that perhaps investors have not yet realized," noted an H.C. Wainwright & Co. report.

more>

Biotech Firm’s T-Cell Therapy Gets Positive Results in B-Cell Non-Hodgkin’s Lymphoma Study (12/06/2021)

Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from its Phase 1 GLEAN Study of ADI-001, which the firm noted is the first-ever allogeneic, off-the-shelf, gamma delta CAR T investigational cell therapy.

more>

Top Miners’ Share Prices Compelling as Growth Continues (12/06/2021)

Adrian Day, in the Global Analyst newsletter, reviews developments at several companies, three of his favorite large miners and one favorite junior, all of which he says are at very compelling levels to buy.

more>

Inflationary Hubris, the Fed & Gold: Can Inflation Actually Be Good for Everyday Americans? (12/06/2021)

Precious metals expert Michael Ballanger discusses Fed actions and how they affect precious metals.

more>

Marvell Shares Rise Nearly 18% on Q3 Earnings & Q4 Revenue Outlook (12/04/2021)

Shares of Marvell Technology established a new 52-week high after the infrastructure semiconductor solutions firm reported Q3/22 financial results than included a 61% increase in YoY revenue.

more>

The Best Game for Telcos to Get Into (12/02/2021)

Gaming is an estimated $192 billion market, and it is forecasted to grow to almost $400 billion by 2026. Sophic Capital makes the case that telcos need to evolve from being utilities to offering gaming services to attract and keep Gen-Z subscribers.

more>

Firm With New eBook Platform Completes Reverse Takeover, Private Placement Underway (12/02/2021)

Legible Inc. began trading on the Canadian Stock Exchange under the ticker symbol READ after a three-way amalgamation closed.

more>

Golden Sky Stock Rises on Strength of Yukon Drill Results (12/01/2021)

Golden Sky Minerals Corp.'s stock rose almost 20% on volume exceeding 43,000 shares in intraday trading on the strength of drill reports on a Yukon property.

more>

Coverage Initiated on Firm 'Set to Become a Leading, US-Based ISR Uranium Developer' (12/01/2021)

EnCore Energy's acquisition of Azarga Uranium is expected to close shortly, according to a Red Cloud Securities report.

more>

Gold Terra Enters Into Option Agreement With Newmont to Purchase Con Mine (12/01/2021)

The Critical Investor discusses the benefits of the recently acquired Con Mine with Gold Terra Executive Chairman Gerald Panneton.

more>

AI Vision Semiconductor Firm Posts 64% Increase in YoY Revenue Sending Shares Higher (12/01/2021)

Ambarella Inc. shares traded nearly 20% higher after the company reported Q3/22 financial results that included a 64% increase in YoY revenue together with higher gross margins.

more>

More Archives

2021Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes